The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Bonsian Hemofarm to operate part of German Stada production.

Bonsian Hemofarm to operate part of German Stada production. Germany’s pharmaceuticals producer Stada will transfer part of its production in its majority controlled subsidiary Bosnian drug company Hemofarm, ONASA reported. According to Stada CEO Harmut Retzlaff, Hemofarm facilities will be used mainly for Stada’s antibiotics production, adding that the move came in response to the German legislation change under which higher contributions and taxes will be paid as of 2007. RS PM Milorad Dodik stated that the entity government would provide all the necessary conditions to facilitate the process. Hemofarm president Miodrag Babic said that EUR 3mn (KM 5.9mn) worth of investments are planned in the operation of the new product lines. By the end of August or the beginning of September some 30 new workers will be hired, while the antibiotics production is expected to be launched in 2008, when additional 60-70 new employees will be hired.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree